Position in AZN
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$256,399,802
+$73,121,087 QoQ
Shares Held
1,352,177
+45.5% QoQ
Ownership
0.087%
of shares outstanding
% of Portfolio
0.35%
of 13F equity value
Holder Rank
#2
of 116 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Assenagon Asset Management S.A. holds $2,878,468,803 across 10 Drug Manufacturers - General names. AZN ranks #7 (8.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
501,025 | $600,944,465 | |
| 2 | ABBV |
AbbVie Inc.
|
2,097,882 | $527,911,026 | |
| 3 | JNJ |
Johnson & Johnson
|
1,939,364 | $492,540,275 | |
| 4 | MRK |
Merck & Co., Inc.
|
2,702,992 | $347,334,472 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
2,287,888 | $289,051,769 | |
| 6 | PFE |
Pfizer Inc
|
11,902,374 | $286,609,165 | |
| 7 | AZN |
Astrazeneca PLC
This page
|
1,352,177 | $256,399,802 | |
| 8 | AMGN |
Amgen Inc
|
191,247 | $69,254,363 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $256,399,802 | 1,352,177 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $183,278,715 | 929,311 | Shares | Sole | 2026-04-20 | |
| No filing history on record for this holder in this stock. | ||||||